Experts in the production and differentiation of iPSCs

We provide reprogramming and differentiation services and products from healthy and patient-specific iPSCs

Custom reprogramming and differentiation

The expertise that Newcells Biotech has in cellular reprogramming using the licensed Sendai virus vectors has been developed over more than 10 years. The in-depth knowledge means we can derive iPSC lines from customer-supplied samples with high confidence and quality.

Outsourcing reprogramming and routine supply of bespoke differentiated cells allows customers to focus on the downstream use of their iPSC lines in drug discovery and disease research.

Our service capability involves working collaboratively with our customers to develop protocols and processes to produce bespoke differentiated cells and tissues for their specific application. Where the customer has a fully developed protocol we are the outsource partner that ensures they have a reliable supply of cells that integrate with their in-house drug screening or toxicity testing or disease modelling projects.

Customer projects can include tissue sourcing, reprogramming and differentiation to ensure consistency and control across the supply chain. We work with academic and industry teams with the aim of allowing them to focus on the next discovery knowing that they have a quality and consistent source of iPSC derived cells on demand.

If you want to discuss your iPSC project please call us or contact us at

The Newcells Biotech product and service offer

Newcells Biotech Limited
Biomedicine West
International Centre for Life, Times Square
Newcastle upon Tyne, NE1 4EP, UK

Tel: +44 (0)191 241 8695


Newcells Biotech Limited is registered in England, company number: 09389592

Newcells Biotech Limited 2015